Immune Checkpoint Inhibitor Induced Type 1 Diabetes Mellitus: A Pembrolizumab Case Study

Authors

Michael R. Dirks Jr., Providence Milwaukie Family MedicineFollow

Files

Publication Date

5-2022

Keywords

oregon; portland

Disciplines

Endocrinology, Diabetes, and Metabolism | Family Medicine | Medical Education

Clinical Institute

Kidney & Diabetes

Specialty

Family Medicine

Specialty

Endocrinology

Specialty

Graduate Medical Education

Conference / Event Name

Academic Achievement Day, 2022

Location

Milwaukie Family Medicine

Recommended Citation

Dirks Jr., Michael R., "Immune Checkpoint Inhibitor Induced Type 1 Diabetes Mellitus: A Pembrolizumab Case Study" (2022). Milwaukie Family Medicine 2022. 1.
https://digitalcommons.providence.org/oaa_mfm_22/1